Examining microRNA from a simple blood test can help determine whether your child is getting enough sleep.
A new blood test for Alzheimer's disease is up-to 94% accurate at predicting dementia before symptoms appear. The test's accuracy is increased when genetic predisposition and age are taken into account. The new test may eventually replace PET neuroimaging, currently considered the gold standard, for early detection of Alzheimer's.
A new blood test to detect biomarkers for Alzheimer's disease is set to undergo trials in the Fall. The test will be able to identify traces of amyloid beta in blood samples with a high degree of accuracy.
Neurofilament light protein in plasma may be a noninvasive biomarker for neurodegeneration associated with Alzheimer's disease.
A new biomarker for fibromyalgia has been identified in blood samples taken from patients suffering from the condition.
Researchers have identified biomarkers in the blood which can help determine the severity of a person's pain level. The findings could help doctors to accurately measure pain and stem the opioid crisis.
Researchers report a new blood test can help detect neurological damage associated with Alzheimer's disease before any of the cognitive symptoms appear. Additionally, researchers report the test may be applied to help identify brain damage associated with TBI, stroke and multiple sclerosis.
Artificial IntelligenceDeep LearningFeaturedGeneticsMachine LearningNeuroscienceNeurotechOpen Neuroscience Articles··5 min read
A new blood test can help identify your body's precise internal time clock in relation to external time. Researchers say the test could help examine the impact of misaligned circadian clocks in a wide range of diseases.
Researchers have developed a new blood test capable of detecting biomarkers of Alzheimer's disease long before the first symptoms appear.
A new method of examining blood plasma allowed researchers to identify specific chemical bonds within the blood. The new technique allowed researchers to accurately distinguish between Alzheimer's disease and Lewy body dementia, thus reducing cases of misdiagnosis.